<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" >
<channel>
	<title><![CDATA[MSNI: Filippini: Anti-infiammatori ( Fans ) e dolore, nuovo stop da Lancet]]></title>
	<link>https://msni.it/bookmarks/view/23279/filippini-antiinfiammatori-fans-e-dolore-nuovo-stop-da-lancet</link>
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://msni.it/bookmarks/view/23279/filippini-antiinfiammatori-fans-e-dolore-nuovo-stop-da-lancet</guid>
	<pubDate>Mon, 10 Jun 2013 19:09:27 +0200</pubDate>
	<link>https://msni.it/bookmarks/view/23279/filippini-antiinfiammatori-fans-e-dolore-nuovo-stop-da-lancet</link>
	<title><![CDATA[Filippini: Anti-infiammatori ( Fans ) e dolore, nuovo stop da Lancet]]></title>
	<description><![CDATA[Nuovo, importante e speriamo ascoltato lavoro sul rapporto rischio beneficio dei farmaci antinfiammatori non steroidei (FANS). Sul sito di Marco Filippini, l’esperienza a difesa del malato per raggiungere gli standard europei in fatto di terapia del dolore. Da: Coxib and traditional NSAID …: meta-analyses of individual participant data from randomised trials. The Lancet, 2013.<p>URL del Link: <a href="https://iqandpartnersblog.wordpress.com/2013/06/10/anti-infiammatori-fans-e-dolore-marco-filippini-nuovo-stop-da-lancet/">https://iqandpartnersblog.wordpress.com/2013/06/10/anti-infiammatori-fans-e-dolore-marco-filippini-nuovo-stop-da-lancet/</a></p>]]></description>
	<dc:creator>IQandPartners</dc:creator>
</item>

</channel>
</rss>